Evidence map›Paper›PMID 42523698›Full record

ArticleFrontiers in immunology2026

Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report.

Zhenpeng Li, Xiuxiu Yi, Jie Fu, Yan Liang, Sensen Zhang, Xv Yang, Zhonghai Du

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhenpeng LiFirst Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Xiuxiu YiWeifang Municipal Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.
Jie FuWeifang Municipal Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.
Yan LiangWeifang Municipal Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.
Sensen ZhangWeifang Municipal Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.
Xv YangWeifang Municipal Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.
Zhonghai DuWeifang Municipal Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune checkpoint inhibitors (ICIs) have revolutionized the management of gastric cancer; however, they can lead to rare immune-related adverse events (irAEs) affecting the urinary system. Herein, we report a case of non-bacterial cystitis complicated by acute kidney injury (AKI) in a 59-year-old male patient with Alpha-fetoprotein-producing gastric carcinoma (AFP-GC). Following treatment with toripalimab combined with SOX chemotherapy, the patient developed urinary tract irritation symptoms, gross hematuria, and stage II AKI. Cystoscopy revealed diffuse mucosal hemorrhage, and biopsy demonstrated extensive infiltration of CD3

Indexed as

Adenocarcinomaalpha-FetoproteinsAntibodies, Monoclonal, HumanizedCystitisImmune Checkpoint InhibitorsStomach NeoplasmsAcute Kidney InjuryHumansMaleMiddle Agedalpha-FetoproteinsAntibodies, Monoclonal, HumanizedImmune Checkpoint Inhibitorstoripalimabalpha-fetoprotein-producing gastric carcinomacystitisimmune checkpoint inhibitorsimmune-related adverse eventstoripalimab

Identifiers

PMID42523698
PMCPMC13407524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.